Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,368.85
(
-1.67%
)
US TECH 100
22,411.20
(
-2.35%
)
Dow Jones
45,166.64
(
-1.73%
)
Brent Oil
106.89
(
0.00%
)
Bitcoin
66,099.53
(
-0.36%
)
News Focus
News Focus
Post# of 257300
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122817
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 195033

Friday, 12/18/2015 10:32:27 AM

Friday, December 18, 2015 10:32:27 AM

Post# of 257300
PTLA completes BLA submission for Andexanet Alfa (FXa reversal agent):

http://finance.yahoo.com/news/portola-pharmaceuticals-completes-bla-submission-130000329.html

The name, Annexa A, which PTLA had used in prior investor communications, has apparently been discarded.

Please see #msg-116997511 for background info on the phase-3 and phase-4 program for this drug.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today